ECM
Endurant Capital Management Portfolio holdings
AUM
$17.4M
1-Year Return
4.95%
This Quarter Return
+3.73%
1 Year Return
+4.95%
3 Year Return
+16.8%
5 Year Return
+58.39%
10 Year Return
–
AUM
$290M
AUM Growth
+$44.4M
(+18%)
Cap. Flow
+$37.8M
Cap. Flow
% of AUM
13.05%
Top 10 Holdings %
Top 10 Hldgs %
50.21%
Holding
82
New
24
Increased
19
Reduced
13
Closed
21
Top Buys
| 1 |
Bristol-Myers Squibb
BMY
|
$21.3M |
| 2 |
Integra LifeSciences
IART
|
$13.3M |
| 3 |
AbbVie
ABBV
|
$11.9M |
| 4 |
AdaptHealth
AHCO
|
$9.76M |
| 5 |
Encompass Health
EHC
|
$8.77M |
Top Sells
| 1 |
Medtronic
MDT
|
$6.95M |
| 2 |
SI-BONE Inc
SIBN
|
$6.65M |
| 3 |
ICU Medical
ICUI
|
$6.55M |
| 4 |
Labcorp
LH
|
$6.3M |
| 5 |
Centene
CNC
|
$5.58M |
Sector Composition
| 1 | Healthcare | 97.22% |
| 2 | Industrials | 0% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
PDCO
26
DELISTED
Patterson Companies, Inc.
PDCO
| $3.94M | 1.16% |
+163,415
| New | +$3.94M |
|
27
Cartesian Therapeutics
RNAC
$263M
| $3.75M | 1.11% |
50,402
-8,909
| -15% | -$663K |
|
28
Aclaris Therapeutics
ACRS
$217M
| $3.68M | 1.09% |
1,432,817
-295,970
| -17% | -$761K |
|
|
VAPO
29
DELISTED
Vapotherm, Inc. Common Stock
VAPO
| $3.65M | 1.08% |
+15,709
| New | +$3.65M |
|
30
Haemonetics
HAE
$2.58B
| $3.63M | 1.07% |
41,607
+12,670
| +44% | +$1.11M |
|
31
PetMed Express
PETS
$62.2M
| $3.35M | 0.99% |
+105,895
| New | +$3.35M |
|
32
Quest Diagnostics
DGX
$20.1B
| $3.33M | 0.98% |
+29,041
| New | +$3.33M |
|
|
CALT
33
DELISTED
Calliditas Therapeutics AB American Depositary Shares
CALT
| $2.68M | 0.79% |
111,467
-48,751
| -30% | -$1.17M |
|
34
Prothena Corp
PRTA
$440M
| $2.63M | 0.78% |
262,773
-141,020
| -35% | -$1.41M |
|
35
MacroGenics
MGNX
$119M
| $2.45M | 0.73% |
+97,374
| New | +$2.45M |
|
|
TBIO
36
DELISTED
Translate Bio, Inc. Common Stock
TBIO
| $2.41M | 0.71% |
+176,710
| New | +$2.41M |
|
37
Fate Therapeutics
FATE
$110M
| $2.25M | 0.66% |
56,210
-4,682
| -8% | -$187K |
|
38
Alcon
ALC
$38.9B
| $2.19M | 0.65% |
+38,373
| New | +$2.19M |
|
|
APTO
39
DELISTED
Aptose Biosciences, Inc.
APTO
| $2.07M | 0.61% |
+767
| New | +$2.07M |
|
40
Immunic
IMUX
$76.4M
| $2.06M | 0.61% |
+110,911
| New | +$2.06M |
|
41
Bio-Rad Laboratories Class A
BIO
$7.79B
| $2.02M | 0.6% |
3,916
+411
| +12% | +$212K |
|
|
FPRX
42
DELISTED
Five Prime Therapeutics, Inc.
FPRX
| $1.98M | 0.59% |
421,398
+184,224
| +78% | +$866K |
|
43
Kiniksa Pharmaceuticals
KNSA
$2.63B
| $1.8M | 0.53% |
+117,480
| New | +$1.8M |
|
44
DaVita
DVA
$9.75B
| $1.8M | 0.53% |
+21,002
| New | +$1.8M |
|
|
LMNX
45
DELISTED
Luminex Corp
LMNX
| $1.79M | 0.53% |
+68,131
| New | +$1.79M |
|
|
ALBO
46
DELISTED
Albireo Pharma, Inc. Common Stock
ALBO
| $1.74M | 0.51% |
+52,131
| New | +$1.74M |
|
47
Arcturus Therapeutics
ARCT
$445M
| $1.48M | 0.44% |
+34,485
| New | +$1.48M |
|
|
SAGE
48
DELISTED
Sage Therapeutics
SAGE
| $1.44M | 0.43% |
+23,588
| New | +$1.44M |
|
49
Quince Therapeutics
QNCX
$85.4M
| $1.09M | 0.32% |
+21,827
| New | +$1.09M |
|
50
Baxter International
BAX
$12.1B
| $1.01M | 0.3% |
12,575
-29,864
| -70% | -$2.4M |
|